Preventing Chronic Disease | Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China - CDC

full-text ►

Preventing Chronic Disease | Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China - CDC

Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China

Navigate This Article

• Abstract
• Introduction
• Methods
• Results
• Discussion
• Acknowledgments
• Author Information
• References
• Tables

Bingying Pan; Xiongfei Chen; Xueji Wu; Jinxiang Li; Jipeng Li; Yaohui Li; Xiaommeng Hao; Huazhang Liu

Suggested citation for this article: Pan B, Chen X, Wu X, Li J, Li J, Li Y, et al. Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China. Prev Chronic Dis 2014;11:130091. DOI: http://dx.doi.org/10.5888/pcd11.130091.

PEER REVIEWED

Abstract

Introduction
This article reports on the prevalence of noncommunicable diseases (NCDs) and their risk factors in the city of Guangzhou, China, and shows a trend toward epidemic proportions when municipal data are compared with provincial data.

Methods
We conducted the Guangzhou Community Health Survey in the 12 administrative districts of Guangzhou to learn about NCDs and their risk factors. A community-based, face-to-face survey with a stratified multistage cluster sampling was used. Information was gathered on 27,743 respondents, aged 0 to 108 years, with a male to female ratio of 1 to 1. All participants completed a questionnaire, and those aged 15 years or older had a physical examination. Survey results were compared with the provincial results of the 2002 Guangdong Nutrition and Health Survey (GNHS).

Results
The data were weighted to the respondent’s probability of selection and to the age- and sex-specific population. Prevalence estimate of self-reported NCDs was 16.0%. Hypertension and diabetes were reported as the most important NCDs. Of those who responded, 6.8% reported having more than 2 chronic conditions. The adjusted prevalence of hypertension decreased by 13.3% since 2002. Awareness, treatment, and control of hypertension and diabetes were improved. The estimated prevalence of current smoking decreased, and the prevalence of former smoking increased from 2002. However, the prevalence of overweight and obesity, especially central obesity, increased.

Conclusion
Results were encouraging with regard to hypertension and diabetes. However, the unfavorable trends, especially for overweight, central obesity, and passive smoking, call for additional action.

Author Information

Corresponding Author: Huazhang Liu, Guangzhou Center for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China. Telephone: +8620-36052333-1812. E-mail: huazhangliu@yeah.net.

Author Affiliations: Bingying Pan, Xiongfei Chen, Xueji Wu, Department of Primary Public Health, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China; Jinxiang Li, Jipeng Li, Department of Preventive Disease, Zengcheng Center for Disease Control and Prevention, Guangzhou, Guangdong, China; Yaohui Li, Xiaommeng Hao, Department of Preventive Disease, Luogang Center for Disease Control and Prevention, Guangzhou, Guangdong, China.

Top of Page

References

1. Alwan A, Maclean DR, Riley LM, d’Espaignet ET, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010;376(9755):1861–8. CrossRef PubMed
2. Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011;377(9781):1949–61. CrossRef PubMed
3. Hubacek K, Guan D, Barua A. Changing lifestyles and consumption patterns in developing countries: a scenario analysis for China and India. Futures 2007;39(9):1084–96. CrossRef
4. National Bureau of Statistics of China. National 5th Census Assembly (2000) and National 6th Census Assembly (2010). http://www.stats.gov.cn/tjsj/pcsj/ Accessed April 18, 2013.
5. Weng F, Jiang Y, Dai L, Huang L, Cai M, Qiu X. Analysis of causes of death in a national monitoring site between 2004 and 2008, Yuexiu, Guangzhou. Nan Fang Yi Ke Da Xue Xue Bao 2009;35(6):43–5.
6. Tan XH, Zhang Y. [Analysis of causes of death and potential years of life lost in 7 districts of Guangzhou]. Chinese. Nan Fang Yi Ke Da Xue Xue Bao 2011;31(6):1075–7. PubMed
7. Lao XQ, Zhang YH, Wong MC, Xu YJ, Xu HF, Nie SP, et al. The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China. BMC Public Health 2012;12:64. CrossRef PubMed
8. Ma WJ. The final report of the Guangdong Nutrition and Health Survey in 2002. Guangdong People’s Publisher: Guangzhou, China; 2004.
9. Statistics Bureau of Guangzhou City. Guangzhou 5th Census Assembly; 2000. http://www.gzstats.gov.cn/pchb/dwcrk/. Accessed February 28, 2013.
10. 1999 World Health Organization–International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999;17(2):151–83. PubMed
11. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 2007;25(9):1807–11. CrossRef PubMed
12. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001;38(4):827–32. PubMed
13. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006;24(6):1187–92. CrossRef PubMed
14. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya J-C. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens 2006;20(1):91–2. CrossRef PubMed
15. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001;19(10):1717–25. CrossRef PubMed
16. Kronborg CN, Hallas J, Jacobsen IA. Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens 2009;3(1):19–24.CrossRef PubMed
17. Liu Z. Dietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveys. Am J Hypertens 2009;22(9):929–33. CrossRef PubMed
18. Ma WJ, Xu YJ, Xu HF, Nie SP, Li JS, Fu CX, et al. Analysis on epidemiological characteristics and control effect of hypertension in Guangdong. South China J Prev Med 2003;9(6):20–4.
19. Nogueira D, Faerstein E, Coeli CM, Chor D, Lopes Cde S, Werneck GL. Awareness, treatment, and control of arterial hypertension: Pró-Saúde Study, Brazil]. Portuguese. Rev Panam Salud Publica 2010;27(2):103–9. Portuguese. PubMed
20. Costanzo S, Di Castelnuovo A, Zito F, Krogh V, Siani A, Arnout J, et al. Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction — the impact of migration as a model of gene-environment interaction project. J Hypertens 2008;26(12):2303–11. CrossRef PubMed
21. Angell SY, Garq RK, Gwynn RC, Bash L, Thorpe LE, Frieden TR. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes 2008;1(1):46–53. CrossRef PubMed
22. Ma WJ, Chen MF, Li JS, Xu YJ, Xu HF, Nie SP, et al. [Analysis on epidemiological characteristics and control effect of diabetes in Guangdong]. Chinese. Chinese Journal of Prevention and Control of Chronic Noncommunicable Diseases 2004;12(6):270–2.
23. Sixth National Population Census. National Bureau of Statistics of China: 2010.
24. Xiao L, Yang J, Wan X, Yang GH. [What is the prevalence of smoking in China]. Chinese. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30(1):30–3.PubMed
25. Xu YJ, Ma WJ, Xu HF, Li JS, Nie SP, Li HK, et al. Analysis on smoking pattern and relative risk factors in inhabitants aged 15 or elder in Guangdong province. Chinese Journal of Public Health 2005;21(8):899–901.
26. Reynolds K, Gu D, Whelton PK, Wu X, Duan X, Mo J, et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring) 2007;15(1):10–8. CrossRef PubMed
27. Dong ZQ, Ma WJ, Xu YJ, Li JS, Nie SP, Xu HF, et al. Analysis on epidemiological characteristics of central obesity of population aged eighteen and over in Guangdong Province in 2002. Chinese Journal of Public Health 2005;21(3):264–6.
28. Macia E, Duboz P, Gueye L. Prevalence of obesity in Dakar. Obes Rev 2010;11(10):691–4. CrossRef PubMed
29. Abolfotouh MA, Soliman LA, Mansour E, Farghaly M, El Dawaiaty AA. Central obesity among adults in Egypt: prevalence and associated morbidity. East Mediterr Health J 2008;14(1):57–68. PubMed
30. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75(1):72–80. CrossRef PubMed
31. Li JS, Ma WJ, Xu YJ, Xu HF, Nie SP, Li HK, et al. Investigation on drinking behaviors among inhabitants aged over 15 years in Guangdong province. Chinese Journal of Public Health 2006;22(7):775–6.
32. Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, Tian S, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 2011;29(7):1303–10. CrossRef PubMed